Progress in nano and flow chemistry reshaping the production of fine chemicals and drugs

Due to low turnover numbers, leaching of the metal and quick catalyst deactivation, industry -- eminent colleagues wrote in a prestigious journal in early 2016 -- would not use immobilized transition metal complexes as catalysts (1). Joint progress in flow chemistry and in the application of nanochemistry to catalyst making, however, is actually reshaping the way the fine and the pharmaceutical industries produce the active substances for which they exist.